• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcareBiotechnology & Medical ResearchIcosavax
    Picture of Icosavax logo

    ICVX — Icosavax Share News

    $15.310.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeMid CapMomentum Trap
    • Market Cap
      $766.88m
    • Enterprise Value
      $537.68m
    • Revenue
      $0.58m
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • ICVX Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    ICVX Dividends
    • Icosavax up nearly three-fold after stellar Nasdaq debut

      29/07/2021 17:36
    • NASDAQ RESUMED AT 11:50 AM

      29/07/2021 16:50
    • NASDAQ TRADE HALT CONTINUES VOLATILITY TRADING PAUSE AT 11:41 AM

      29/07/2021 16:41
    • Brief: Icosavax Inc Shares Nearly Double In Nasdaq Debut

      29/07/2021 16:40
    • NASDAQ RESUMED AT 11:38 AM

      29/07/2021 16:38
    • NASDAQ TRADE HALT CONTINUES VOLATILITY TRADING PAUSE AT 11:33 AM

      29/07/2021 16:33
    • NASDAQ RESUMED AT 11:17 AM

      29/07/2021 16:17
    • NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 04:01 AM

      29/07/2021 09:01
    • Brief: Icosavax Announces Pricing Of Upsized IPO Of 12.13 Mln Shares Of Common Stock

      29/07/2021 04:36
    Previous1234Next

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.